1. Therapeutic proteins;Dimitrov;Methods Mol Biol,2012
2. Three years of paediatric regulation in the European Union;Olski;Eur J Clin Pharmacol,2011
3. FDA Pediatric Information Incorporated Into Human Prescription Drug and Biological Products Labeling. 2014. Draft guidance Accessed http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM341394.pdf
4. EMA Official Journal of the European Union. Communication from the Commission: Guideline on the format and content of applications for agreement or modification of a paediatric investigation plan and requests for waivers or deferrals and concerning the operation of the compliance check and on criteria for assessing significant studies /C 234/01) 2010 http://ec.europa.eu/health/files/eudralex/vol-1/com_2008_jo243/com_2008_243_en.pdf/
5. Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices;Morford;Birth Defects Res B Dev Reprod Toxicol,2011